slides · global inventory
Testimonial
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 3,034
Current window 1,891-1,920
Pages 102
Rows per page 30
Slide type
1,891-1,920 of 3,034
358
The slide uses a Q&A format to highlight skepticism among medical professionals regarding a drug's marketing presentation.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
359
The slide uses direct quotes to undermine the credibility of the company's sales representatives and the drug's market reception.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
360
The slide uses a summary headline followed by a verbatim quote with key phrases highlighted in yellow.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
361
The slide uses direct quotes from a pediatric endocrinologist to undermine the viability of a drug (Vykat/diazoxide).Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
367
The slide highlights a direct contradiction between the company's marketing (Vykat) and expert clinical opinion.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
375
The slide uses highlighted text to emphasize key phrases from the expert's transcript.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
378
The slide uses a 'before-after' narrative structure to expose the contradiction between the physician's initial interest and his clinical assessment.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
394
The slide uses expert interview transcripts to undermine the value proposition of the drug Vykat.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
395
The slide uses a Q&A format to highlight the physician's reluctance to prescribe Vykat and their familiarity with the risks of diazoxide.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
397
The slide uses direct quotes to build a case against the company's commercial execution.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
398
The slide uses a Q&A format to expose the contradiction between the drug's intended use and its actual clinical viability.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
399
The slide uses direct quotes from an expert consultation to illustrate market resistance.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
404
The slide uses a summary paragraph followed by a direct quote, highlighting the expert's negative sentiment.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
405
The slide uses direct quotes from an expert consultation to highlight the drug's perceived lack of efficacy and the barrier of administrative burden.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
406
The slide uses a Q&A format to highlight physician reluctance.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
407
The slide presents a summary of an expert interview, highlighting the endocrinologist's preference for GLP-1s over Vykat for PWS patients.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
408
The slide uses direct quotes from an endocrinologist to frame potential medical risks as a barrier to adoption.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
409
The slide uses direct quotes to build a narrative of expert doubt.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
411
The slide uses a Q&A format to highlight the administrative burden and slow approval process for the drug Vykat.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
413
The slide uses a Q&A format to present primary research findings from a consultation call.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
03
The slide uses anecdotal evidence to frame the company's leadership as a 'villain' figure, specifically highlighting potential legal and regulatory scrutiny.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Testimonials from Industry Experts1 hit
04
The slide uses quotes to build a narrative of corporate malfeasance and systemic gaming of organ allocation processes.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Testimonials from Industry Experts1 hit
05
The quote highlights a conflict between administrative credit holds and urgent clinical needs for heart transplants.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Testimonials from Industry Experts1 hit
06
The slide uses a direct quote to expose a contradiction between company claims and user experience.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Testimonials from Industry Experts1 hit
07
The slide uses a direct quote to frame TransMedics as a failing company due to poor leadership and predatory behavior, drawing an analogy to Blackberry's decline.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Testimonials from Industry Experts1 hit
18
The slide uses direct quotes to build a narrative of customer churn risk, specifically highlighting the threat of switching to OrganOX.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Critique of TransMedics Group Inc.1 hit
62
The slide uses direct quotes from industry experts to frame the company's pricing as predatory and its leadership as arrogant.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
64
The slide uses direct quotes from MGH staff to argue that TransMedics' business model is built on control rather than efficiency.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
76
The slide uses a Q&A format to highlight internal confusion and the visibility of national operations via an internal app.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
81
The slide uses a combination of summary text and a direct, highlighted quote from a UCSF administrator to substantiate claims of fraudulent billing.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit